Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Induction of astrocyte reactivity promotes retinal ganglion cell degeneration in human pluripotent stem cell models through complement C3 activation
Author Affiliations & Notes
  • Cátia Gomes
    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Kang-Chieh Huang
    Department of Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Jade Harkin
    Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Aaron Thomas Baker
    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Jason Hughes
    Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Yanling Pan
    Department of Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Sailee Lavekar
    Department of Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Kaylee Tutrow
    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Melody Hernandez
    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Theodore Cummins
    Department of Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Scott Canfield
    Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Jason S Meyer
    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Footnotes
    Commercial Relationships   Cátia Gomes Sanofi Pharmaceuticals, Code F (Financial Support); Kang-Chieh Huang None; Jade Harkin None; Aaron Baker None; Jason Hughes None; Yanling Pan None; Sailee Lavekar None; Kaylee Tutrow None; Melody Hernandez None; Theodore Cummins None; Scott Canfield None; Jason Meyer Sanofi Pharmaceuticals, Code F (Financial Support)
  • Footnotes
    Support  BrightFocus - G2022003F; NEI - U24EY033269-02S1; NEI - R01EY033269-03S1
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4513. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Cátia Gomes, Kang-Chieh Huang, Jade Harkin, Aaron Thomas Baker, Jason Hughes, Yanling Pan, Sailee Lavekar, Kaylee Tutrow, Melody Hernandez, Theodore Cummins, Scott Canfield, Jason S Meyer; Induction of astrocyte reactivity promotes retinal ganglion cell degeneration in human pluripotent stem cell models through complement C3 activation. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4513.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Astrocytes closely associate with retinal ganglion cells (RGCs) in the nerve fiber layer of the retina and optic nerve, where they provide support for RGCs but can contribute to RGC degeneration in a glaucomatous state. Complement cascade activation is a consistent feature observed in glaucoma, and neurotoxic reactive astrocytes express increased levels of complement C3. However, our understanding of how astrocytes promote neurotoxicity, and how complement activation is involved in astrocyte-mediated neurodegeneration remain incomplete.

Methods : Using human pluripotent stem cell (hPSC)-derived RGCs and astrocytes, we explored how reactive astrocytes contribute to RGC degeneration, and how complement C3 is involved in astrocyte reactivity. hPSC-astrocytes were induced to a reactive phenotype through incubation with C1q, TNFα and IL1α, and their neurotoxic effect was determined through co-cultures with RGCs. Furthermore, shRNA approaches were used to modulate C3 in astrocytes.

Results : Reactive astrocytes exhibited a hypertrophic profile, upregulation of inflammatory genes, and increased secretion of several cytokines. Reactive astrocytes promoted marked morphological changes to RGCs, including neurite retraction and reduced neurite complexity, through direct contact and via secreted factors in transwell co-cultures. Moreover, to better mimic the compartmentalized nature of RGCs and location of reactive astrocytes in the optic nerve head, microfluidic devices were developed to properly orient astrocytes along the proximal axonal compartment. Results showed a detrimental effect of reactive astrocytes over RGC axonal compartment. Importantly, complement activation contributed to the acquisition of the reactive phenotype by hPSC-derived astrocytes, as shRNA-mediated reduction of complement C3 resulted in a less pronounced hypertrophic profile and attenuated reactivity-associated features in astrocytes.

Conclusions : These results demonstrate that reactive astrocytes promote RGC neurodegeneration in a microfluidic platform that mimics reactive astrocyte orientation along the proximal axon. Results of this study demonstrate a role for the complement cascade in this neuroinflammatory response, and that the modulation of the complement cascade in reactive astrocytes could represent a novel therapeutic strategy for neuroinflammatory aspects of glaucoma.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×